Tapping regional investors is a capital idea
Mark EggletonContributor
Australian antibiotic developer Recce Pharmaceuticals has turned to Asia to secure strategic investors to help with funding and, more pertinently, to potentially achieve local market penetration.
According to Recce’s executive director James Graham this turn to Asia is born out of two drivers. “There’s the patient population which will lead to consumer demand and Asia provides access to smart, patient capital," he says.
Loading...
Mark Eggleton writes and compiles special reports for The Australian Financial Review. Email Mark at meggleton@afr.com.au
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Financial services
Fetching latest articles